Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Summary

This is a prospective, one-arm, exploratory clinical study to observe and evaluate the efficacy and safety of Anlotinib hydrochloride capsules in patients with advanced liver cancer.

Timeline

Start

2018-12-31

Primary completion

2019-12-31

Completion

2020-12-31

Drugs

Indications